The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies-Reference-Cited by-同舟云学术

The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies

Published:2010-08-25 Issue:2 Volume:151 Page:167-178
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Buchner Maike,Brantner Philipp,Stickel Natalie,Prinz Gabriele,Burger Meike,Bär Constance,Dierks Christine,Pfeifer Dietmar,Ott Ariane,Mertelsmann Roland,Gribben John G.,Veelken Hendrik,Zirlik Katja

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08316.x/fullpdf

Reference61 articles.

1. Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab;Awan;Blood,2009

2. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance;Balakrishnan;Blood,2009

3. Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia;Biagi;Clinical Cancer Research,2005

4. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia;Buchner;Cancer Research,2009

5. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment;Burger;Blood,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies;Frontiers in Cell and Developmental Biology;2023-10-31

2. The current status of anti-GPCR drugs against different cancers;Journal of Pharmaceutical Analysis;2020-12

3. Chemokine receptor CXCR4: An important player affecting the molecular-targeted drugs commonly used in hematological malignancies;Expert Review of Hematology;2020-11-10

4. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies;Frontiers in Oncology;2020-10-26

5. The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy;Haematologica;2020-06